LivaNova PLC

NASDAQ:LIVN  
54.24
-0.48 (-0.88%)
4:11:34 PM EDT: $54.24 0.00 (0.00%)
Products

FDA Says Livanova (Tandemlife) Recalls Lifesparc System For Risk Of Unintentional Extended Pump Stop During Controller Critical Failure

Published: 09/30/2022 15:03 GMT
LivaNova PLC (LIVN) - FDA Says Livanova (tandemlife) Recalls Lifesparc System for Risk of Unintentional Extended Pump Stop During Controller Critical Failure.
FDA Says Has Identified Recall of Lifesparc System As a Class I Recall.
FDA Says Livanova (tandemlife) is Recalling the Lifesparc Controller, Part of the Lifesparc System Due to a Software Malfunction.
FDA Says Livanova Reported There Have Been 66 Complaints, and the FDA Has Received Two Injuries and No Deaths Due to This Issue in Lifesparc System.
Further Company Coverage: Livno ((reuters.
Briefs@thomsonreuters.
Com;)).